Arca
Skip to content
Tools
Tools

DIO1: Type I iodothyronine deiodinase

Plays a crucial role in the metabolism of thyroid hormones (TH) and has specific roles in TH activation and inactivation by deiodination.

  • Drugs that act on it: 1
  • Approved: 1
  • In phases 1 to 3: 0
  • Sponsors: 1

Who is on it, and how far along

Every drug ChEMBL records acting on DIO1, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 1

Approved1

  • Propylthiouracil

Phase 30

    Phase 20

      Phase 10

        The landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
        DrugFurthest stageSponsorModalityActionOpen trials
        PropylthiouracilBoxed warningApprovedPH HealthSmall moleculeInhibitorType I iodothyronine deiodinase (Type-I 5'-deiodinase) (DIOI) (Type 1 DI) (5DI) inhibitor1

        Open trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 1 in all, from ClinicalTrials.gov.
        TrialDrugPhaseStatusLead sponsorFirst posted
        Somesthesia in Cancer Patients: Variability and Influence on Eating ExperiencePropylthiouracil—Not yet recruitingHospices Civils de LyonJan 31, 2025

        Diseases most associated with it

        Open Targets association score, 0 to 1; all associations
        Thyroid hormone metabolism, abnormal, 2
        0.65
        Hyperthyroidism
        0.51
        Hypothyroidism
        0.37
        Abnormality of the thyroid gland
        0.37
        Hashimoto thyroiditis
        0.34
        Thyroid gland disorder
        0.32
        Autoimmune thyroid disease
        0.30
        Thyrotoxicosis
        0.26
        Clear cell renal carcinoma
        0.08

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2019, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-18. Gene name, function (UniProt P49895, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

        Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.